1133 related articles for article (PubMed ID: 15374659)
1. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.
Servin AL
FEMS Microbiol Rev; 2004 Oct; 28(4):405-40. PubMed ID: 15374659
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application.
Cheikhyoussef A; Pogori N; Chen W; Zhang H
Int J Food Microbiol; 2008 Jul; 125(3):215-22. PubMed ID: 18514343
[TBL] [Abstract][Full Text] [Related]
3. Immunology and probiotic impact of the newborn and young children intestinal microflora.
Bezirtzoglou E; Stavropoulou E
Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacteria and lactobacilli in human health.
Orrhage K; Nord CE
Drugs Exp Clin Res; 2000; 26(3):95-111. PubMed ID: 10941602
[TBL] [Abstract][Full Text] [Related]
6. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
7. Portrait of a canine probiotic Bifidobacterium--from gut to gut.
O'Mahony D; Murphy KB; MacSharry J; Boileau T; Sunvold G; Reinhart G; Kiely B; Shanahan F; O'Mahony L
Vet Microbiol; 2009 Oct; 139(1-2):106-12. PubMed ID: 19523775
[TBL] [Abstract][Full Text] [Related]
8. Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host.
Leser TD; Mølbak L
Environ Microbiol; 2009 Sep; 11(9):2194-206. PubMed ID: 19737302
[TBL] [Abstract][Full Text] [Related]
9. Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.
Picard C; Fioramonti J; Francois A; Robinson T; Neant F; Matuchansky C
Aliment Pharmacol Ther; 2005 Sep; 22(6):495-512. PubMed ID: 16167966
[TBL] [Abstract][Full Text] [Related]
10. Interactions between the microbiota and the intestinal mucosa.
Schiffrin EJ; Blum S
Eur J Clin Nutr; 2002 Aug; 56 Suppl 3():S60-4. PubMed ID: 12142966
[TBL] [Abstract][Full Text] [Related]
11. Factors involved in the colonization and survival of bifidobacteria in the gastrointestinal tract.
González-Rodríguez I; Ruiz L; Gueimonde M; Margolles A; Sánchez B
FEMS Microbiol Lett; 2013 Mar; 340(1):1-10. PubMed ID: 23181549
[TBL] [Abstract][Full Text] [Related]
12. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
Zárate G; Nader-Macias ME
Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
[TBL] [Abstract][Full Text] [Related]
13. Lactic acid bacteria as probiotics.
Ljungh A; Wadström T
Curr Issues Intest Microbiol; 2006 Sep; 7(2):73-89. PubMed ID: 16875422
[TBL] [Abstract][Full Text] [Related]
14. Human gut microbiota and bifidobacteria: from composition to functionality.
Turroni F; Ribbera A; Foroni E; van Sinderen D; Ventura M
Antonie Van Leeuwenhoek; 2008 Jun; 94(1):35-50. PubMed ID: 18338233
[TBL] [Abstract][Full Text] [Related]
15. Lessons from the genomes of bifidobacteria.
Klijn A; Mercenier A; Arigoni F
FEMS Microbiol Rev; 2005 Aug; 29(3):491-509. PubMed ID: 15939502
[TBL] [Abstract][Full Text] [Related]
16. Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut.
Solís G; de Los Reyes-Gavilan CG; Fernández N; Margolles A; Gueimonde M
Anaerobe; 2010 Jun; 16(3):307-10. PubMed ID: 20176122
[TBL] [Abstract][Full Text] [Related]
17. The role of microbiota in infectious disease.
Stecher B; Hardt WD
Trends Microbiol; 2008 Mar; 16(3):107-14. PubMed ID: 18280160
[TBL] [Abstract][Full Text] [Related]
18. Bacterial interference for the prevention and treatment of infections.
Falagas ME; Rafailidis PI; Makris GC
Int J Antimicrob Agents; 2008 Jun; 31(6):518-22. PubMed ID: 18359612
[TBL] [Abstract][Full Text] [Related]
19. Fate, activity, and impact of ingested bacteria within the human gut microbiota.
Derrien M; van Hylckama Vlieg JE
Trends Microbiol; 2015 Jun; 23(6):354-66. PubMed ID: 25840765
[TBL] [Abstract][Full Text] [Related]
20. Probiotic bacteria are antagonistic to Salmonella enterica and Campylobacter jejuni and influence host lymphocyte responses in human microbiota-associated immunodeficient and immunocompetent mice.
Wagner RD; Johnson SJ; Kurniasih Rubin D
Mol Nutr Food Res; 2009 Mar; 53(3):377-88. PubMed ID: 19065588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
